Key Market Indicators
The American pharmaceutical research and development (R&D) expenditure is projected to reach approximately $167 billion by 2028, up from around $122 billion in 2023. This marks an annual growth rate of 5%. Since 2013, the American pharmaceutical supply has seen a significant increase, growing at an average rate of 10.3% each year. In the global rankings, China, Germany, and South Korea follow the United States, occupying the second, third, and fourth positions respectively in pharmaceutical R&D expenditure.
